Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up

Objective: To assess the frequency and prognostic significance of a basal phenotype in a group of women with screen-detected invasive breast cancers with long-term follow-up and to focus particularly on women with small ( < 15 mm) breast cancers. Methods: The study group was derived by finding women common to a consecutive series of 1944 invasive breast cancers diagnosed in Nottingham between 1986 and 1998 with a known basal phenotype status and a prospectively collected database of all screen-detected breast cancers. In total, 356 women constituted the study group. Pathological and radiological features were recorded. Basal cell markers used were CK5/6 (cloneD5/16134) and CK14 (clone LL002). Tumours were classified as of basal phenotype if > or = 10% staining was seen with either marker. Results: Of all screen-detected lesions, 43 (12%) had a basal immunophenotype and 313 (88%) were non-basal. There were 15 (35%) and 40 (13%) breast cancer deaths in the basal group and nonbasal groups, respectively ( P = 0.0006). On univariate analysis, nodal stage, histological grade, lympho-vascular invasion (LVI) status, invasive size and basal phenotype had prognostic significance. On multivariate analysis, basal phenotype, LVI and nodal stage maintain prognostic significance. Of the 189 women with < 15 mm lesions, eight of 20 (40%) of the basal group and eight of 169 (5%) of the non-basal group died of breast cancer ( P < 0.0001). On multivariate analysis, basal phenotype was the only factor to maintain independent prognostic significance. Conclusions: Basal phenotype is a powerful prognostic factor for women with small screen-detected invasive breast cancer.

[1]  S. Krishnamurthy.  Morphological and Immunophenotypic Analysis of Breast Carcinomas With Basal and Myoepithelial Differentiation , 2007 .

[2]  Douglas Macmillan,et al.  Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. , 2006, European journal of cancer.

[3]  Ian O Ellis,et al.  Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer? , 2006, AJR. American journal of roentgenology.

[4]  J. Benítez,et al.  Prognostic Significance of Basal-Like Phenotype and Fascin Expression in Node-Negative Invasive Breast Carcinomas , 2006, Clinical Cancer Research.

[5]  Yueh-Hsia Chiu,et al.  Mammographic tumor features can predict long‐term outcomes reliably in women with 1–14‐mm invasive breast carcinoma , 2004, Cancer.

[6]  Jorge S. Reis-Filho,et al.  Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical Outcomes , 2004, Clinical Cancer Research.

[7]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[8]  R. Given-Wilson,et al.  Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: is this a reliable prognostic indicator? , 2004, Clinical radiology.

[9]  T. Nishikawa,et al.  Blood Vessel Invasion as a Predictor of Long-Term Survival for Japanese Patients with Breast Cancer , 2002, Breast Cancer Research and Treatment.

[10]  E. Thurfjell,et al.  Mammographic finding as predictor of survival in 1–9mm invasive breast cancers. Worse prognosis for cases presenting as calcifications alone , 2001, Breast Cancer Research and Treatment.

[11]  I. Ellis,et al.  Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers? , 2003, Clinical radiology.

[12]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[13]  F. Alexander,et al.  The natural history of breast carcinoma , 2000, Cancer.

[14]  Stephen W Duffy,et al.  A novel method for prediction of long-term outcome of women with T1a, T1b, and 10–14 mm invasive breast cancers: a prospective study , 2000, The Lancet.

[15]  L. Tabár,et al.  The natural history of breast carcinoma , 1999, Cancer.

[16]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[17]  S. Pinder,et al.  Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up , 1994, Histopathology.

[18]  C. Carter,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.

[19]  I. O. Ellis,et al.  Confirmation of a prognostic index in primary breast cancer. , 1987, British Journal of Cancer.

[20]  A. Hackett,et al.  MONOCLONAL MARKER THAT PREDICTS EARLY RECURRENCE OF BREAST CANCER , 1987, The Lancet.

[21]  R. Nagle,et al.  Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.